Vergoeding 2018-2022 voor ATC-subgroep N06AA : Niet-selectieve monoamine-heropnameremmers
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| N06AA02 Imipramine | 145.980 | 141.350 | 159.930 | 404.590 | 684.600 |
| N06AA04 Clomipramine | 1.136.000 | 1.158.700 | 1.150.900 | 1.138.500 | 1.218.900 |
| N06AA09 Amitriptyline | 2.343.600 | 2.803.100 | 2.963.100 | 2.817.200 | 2.939.600 |
| N06AA10 Nortriptyline (Nortrilen ®) | 3.847.000 | 3.796.500 | 3.544.300 | 3.643.600 | 3.931.000 |
| N06AA12 Doxepine | 91.149 | 82.811 | 20.812 | 274 | 48 |
| N06AA16 Dosulepine (Prothiaden ®) | 47.055 | 45.837 | 53.372 | 55.440 | 52.767 |
| N06AA21 Maprotiline | 60.317 | 50.288 | 64.938 | 66.575 | 41.027 |
| Totaal | 7.671.101 | 8.078.586 | 7.957.352 | 8.126.179 | 8.867.942 |